+ Follow ANN INTERN MED Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 275976
[Title] => Can cirrhosis or cancer be prevented with interferon/ribavirin in chronic viral hepatitis?
[Summary] => The incidence of hepatocellular cancer (liver cancer) is rising rapidly. According to Surveillance, Epidemiology and End Results (SEER) analyses, liver and intrahepatic biliary cancer rates are increasing at a faster rate than any other cancer-related death. Once a patient is diagnosed clinically, the average life expectancy is less than one year.
[DatePublished] => 2005-05-01 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
ANN INTERN MED
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 275976
[Title] => Can cirrhosis or cancer be prevented with interferon/ribavirin in chronic viral hepatitis?
[Summary] => The incidence of hepatocellular cancer (liver cancer) is rising rapidly. According to Surveillance, Epidemiology and End Results (SEER) analyses, liver and intrahepatic biliary cancer rates are increasing at a faster rate than any other cancer-related death. Once a patient is diagnosed clinically, the average life expectancy is less than one year.
[DatePublished] => 2005-05-01 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest